Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: A United States population-level analysis
Shannon Wongvibulsin, Vartan Pahalyants, Mark Kalinich, William S. Murphy, Kun‐Hsing Yu, Feicheng Wang, Steven T. Chen, Kerry L. Reynolds, Shawn G. Kwatra, Yevgeniy R. Semenov
Topics & Concepts
MedicineIncidence (geometry)Retrospective cohort studyDermatologyPopulationMucositisAdverse effectRashEpidemiologyInternal medicineCumulative incidenceSkin cancerSurgeryCancerCohortChemotherapyOpticsEnvironmental healthPhysicsCancer Immunotherapy and BiomarkersColorectal Cancer Treatments and StudiesCancer Diagnosis and Treatment